$Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib$

Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib

Saved in:

Bibliographic Details
Main Authors:	Valentina Natoli, Serena Palmeri, Ana Isabel Rebollo-Giménez, Caterina Matucci-Cerinic, Paola Bocca, Roberta Caorsi, Stefano Volpi, Riccardo Papa, Alessandro Consolaro, Marco Gattorno, Angelo Ravelli, Silvia Rosina
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	Pediatric Rheumatology Online Journal
Subjects:	Juvenile dermatomyositis Anti-MDA5 antibodies Interstitial lung disease Tofacitinib JAK inhibitors Type I IFN gene signature
Online Access:	https://doi.org/10.1186/s12969-024-01044-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01)

A pilot transcriptomic study of a novel multitargeted BRT regimen for anti–MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy
by: Moe Tokunaga, et al.
Published: (2025-08-01)

Anti-MDA-5 dermatomyositis with tumid lupus-like lesions
by: Kristiana Marie Jordan, BA, et al.
Published: (2025-06-01)

Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
by: Jie Zhao, et al.
Published: (2025-02-01)

Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report
by: Semra Ayduran, et al.
Published: (2024-12-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)

Anti–Melanoma Differentiation Associated Gene 5 (MDA 5) Dermatomyositis Complicated by Spontaneous Pneumomediastinum: A Case Report From South Africa
by: M. Myburgh
Published: (2024-11-01)

Effective Treatment of Livedoid Vasculopathy With Oral Tofacitinib
by: Parvin Mansouri, et al.
Published: (2025-06-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)

Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis
by: Chao Sun, et al.
Published: (2025-07-01)

Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-11-01)

Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
by: Yijia He, et al.
Published: (2025-04-01)

Clinical characteristics and outcomes of anti-MDA5 dermatomyositis: a retrospective study
by: Tulaton Sodsri, et al.
Published: (2025-08-01)

Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis
by: Akira Yoshida, et al.
Published: (2025-07-01)

Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort
by: Sai K. Koyoda, et al.
Published: (2025-01-01)

Experience with tofacitinib in the treatment of resistant rheumatoid arthritis
by: A. R. Babaeva, et al.
Published: (2015-06-01)

Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study
by: Hongxia Xin, et al.
Published: (2025-01-01)

Research progress on tofacitinib in the treatment of chronic actinic dermatitis
by: WU Hui, et al.
Published: (2024-12-01)

Diverse Lenabasum pathway activation in dermatomyositis patients’ blood
by: Nilesh Kodali, et al.
Published: (2025-05-01)

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
by: Darija Logvinova, et al.
Published: (2024-11-01)

EFFICACY AND SAFETY OF TOFACITINIB FOR IMMUNEMEDIATED INFLAMMATORY RHEUMATIC DISEASES (PART II)
by: E. L. Nasonov, et al.
Published: (2020-04-01)

The efficacy of narrowband ultraviolet B phototherapy combination with tofacitinib in the treatment of vitiligo: a randomized controlled trial
by: Xiaoyan Guo, et al.
Published: (2025-12-01)

EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
by: E. Yu. Loginova, et al.
Published: (2020-06-01)

Multisystemic Complications and Rapid Decline in Anti‐MDA‐5 Positive Amyopathic Dermatomyositis: A Case Study
by: Hem Prajapati, et al.
Published: (2025-03-01)

Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
by: Yuanyuan Niu, et al.
Published: (2024-10-01)

Successful treatment of a case of dupilumab-induced psoriasis and alopecia areata with tofacitinib
by: SUN Feifei, et al.
Published: (2025-06-01)

Clinical and Molecular Insights Into Anti-MDA5 Antibody-Positive Dermatomyositis: A Single-Center Retrospective and Transcriptomic Study
by: Ren Y, et al.
Published: (2025-08-01)

Uncommon concurrent pulmonary infections: Aspergillus fumigatus and Lomentospora prolificans in an Anti-MDA5 antibody-positive dermatomyositis patient
by: Maaya Fukumura, et al.
Published: (2025-03-01)

IFN&alpha;/JAK/STAT1 Axis-Induced FBXO4 Modulates Muscle Cell Differentiation via &beta;-Catenin Degradation in Dermatomyositis
by: Yin L, et al.
Published: (2025-06-01)

Tofacitinib as a promising treatment for refractory erythroderma-like Hailey–Hailey disease
by: Huaye Bao, et al.
Published: (2025-12-01)

The marked and rapid therapeutic effect of tofacitinib in combination with subcutaneous methotrexate in a rheumatoid arthritis patient with poor prognostic factors who is resistant to standard disease-modifying antirheumatic drugs and biologicals: A clinical case
by: N. V. Demidova, et al.
Published: (2016-03-01)

Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib
by: Frederik S. Gillesberg, et al.
Published: (2025-01-01)

Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib
by: Albert E. Zhou, MD, PhD, et al.
Published: (2024-12-01)

A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents
by: Andrea Picchianti Diamanti, et al.
Published: (2024-11-01)

Tofacitinib as an adjuvant treatment for pediatric Still's disease
by: Ling Hou, et al.
Published: (2025-08-01)

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
by: Gui-Chen Ling, et al.
Published: (2024-10-01)

Clinical features and prognostic factors of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
by: Li Lian, et al.
Published: (2023-06-01)

Monocyte–macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis‐related interstitial lung disease
by: Jia Shi, et al.
Published: (2025-02-01)

JAK-STAT inhibitors in noninfectious uveitis – A review
by: Richa Pyare, et al.
Published: (2025-06-01)

Altered metabolic profiles of dermatomyositis with different myositis-specific autoantibodies associated with clinical phenotype
by: Nan Wang, et al.
Published: (2024-11-01)